Ascletis Pharma Inc. (1672.HK)

HKD 2.55

(-10.21%)

Total Debt Summary of Ascletis Pharma Inc.

Ascletis Pharma Inc.'s latest annual total debt in 2023 was 8.41 Million CNY , up 98.63% from previous year.
Ascletis Pharma Inc.'s latest quarterly total debt in 2024 Q2 was - CNY , down 0.0% from previous quarter.
Ascletis Pharma Inc. reported annual total debt of 4.23 Million CNY in 2022, up 54.07% from previous year.
Ascletis Pharma Inc. reported annual total debt of 2.75 Million CNY in 2021, up 73.28% from previous year.
Ascletis Pharma Inc. reported quarterly total debt of - CNY for 2024 Q1, down -100.0% from previous quarter.
Ascletis Pharma Inc. reported quarterly total debt of 1.16 Million CNY for 2023 Q1, down -72.43% from previous quarter.

Annual Total Debt Chart of Ascletis Pharma Inc. (2023 - 2016)

Historical Annual Total Debt of Ascletis Pharma Inc. (2023 - 2016)

Year	Total Debt	Total Debt Growth
2023	8.41 Million CNY	98.63%
2022	4.23 Million CNY	54.07%
2021	2.75 Million CNY	73.28%
2020	1.58 Million CNY	-58.38%
2019	3.81 Million CNY	0.0%
2018	- CNY	0.0%
2017	- CNY	0.0%
2016	- CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	- CNY	0.0%
2024 Q1	- CNY	-100.0%
2023 Q1	1.16 Million CNY	-72.43%
2023 FY	8.41 Million CNY	98.63%
2023 Q4	8.41 Million CNY	211.01%
2023 Q3	2.7 Million CNY	-10.96%
2023 Q2	3.03 Million CNY	160.19%
2022 Q3	1.82 Million CNY	4.06%
2022 Q2	1.75 Million CNY	192.64%
2022 Q1	598 Thousand CNY	-78.25%
2022 Q4	4.23 Million CNY	132.67%
2022 FY	4.23 Million CNY	54.07%
2021 FY	2.75 Million CNY	73.28%
2021 Q3	1.18 Million CNY	-69.46%
2021 Q4	2.75 Million CNY	132.66%
2021 Q1	1.74 Million CNY	10.21%
2021 Q2	3.87 Million CNY	121.27%
2020 Q2	2.68 Million CNY	163.11%
2020 Q3	443 Thousand CNY	-83.53%
2020 Q4	1.58 Million CNY	258.24%
2020 Q1	1.02 Million CNY	-73.2%
2020 FY	1.58 Million CNY	-58.38%
2019 Q1	3.52 Million CNY	0.0%
2019 FY	3.81 Million CNY	0.0%
2019 Q4	3.81 Million CNY	140.26%
2019 Q3	1.58 Million CNY	-71.25%
2019 Q2	5.52 Million CNY	56.64%
2018 Q1	- CNY	0.0%
2018 FY	- CNY	0.0%
2018 Q4	- CNY	0.0%
2018 Q3	- CNY	0.0%
2018 Q2	- CNY	0.0%
2017 FY	- CNY	0.0%
2017 Q1	- CNY	0.0%
2017 Q3	- CNY	0.0%
2017 Q4	- CNY	0.0%
2016 FY	- CNY	0.0%

Peer Total Debt Comparison of Ascletis Pharma Inc.

Name	Total Debt	Total Debt Difference
Uni-Bio Science Group Limited	52.86 Million HKD	84.081%
CK Life Sciences Int'l., (Holdings) Inc.	5.93 Billion HKD	99.858%